Drug intelligence / Profile preview

hepatitis b antigen

Development stage
Approved
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Hepatitis B antigen most commonly refers to the hepatitis B surface antigen (HBsAg), a protein present on the outer envelope of the hepatitis B virus (HBV). HBsAg is used as a marker in blood tests to detect acute or chronic HBV infection. Its presence in blood indicates that a person is currently infected with HBV and can transmit the virus to others. The detection of this antigen is one of the earliest signs of infection and forms part of standard diagnostic panels for hepatitis B. In addition to its diagnostic role, purified recombinant HBsAg is also used as the active component in all current hepatitis B vaccines. Mechanistically, it acts as an immunogen—stimulating an immune response that leads to antibody production against HBV[1][5][6].

Brand names
Engerix-BRecombivax HBHeplisav-BPreHevbrioSci-B-VacFendrixBiovac-BElovac BGeneVac-BShanvac-B
Other names
hepatitis B surface antigenHBsAgAustralia antigen

Beyond the preview

Go deeper on hepatitis b antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hepatitis b antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call